Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia

Tomoharu Yasuda, Masaki Shirakata, Atsushi Iwama, Asuka Ishii, Yasuhiro Ebihara, Mitsujiro Osawa, Kazuho Honda, Hisaaki Shinohara, Katsuko Sudo, Kohichiro Tsuji, Hiromitsu Nakauchi, Yoichiro Iwakura, Hisamaru Hirai, Hideaki Oda, Tadashi Yamamoto, Yuji Yamanashi

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Dok-1 and Dok-2 are closely related rasGAP-associated docking proteins expressed preferentially in hematopoietic cells. Although they are phosphorylated upon activation of many protein tyrosine kinases (PTKs), including those coupled with cytokine receptors and oncogenic PTKs like Bcr-Abl, their physiological roles are largely unidentified. Here, we generated mice lacking Dok-1 and/or Dok-2, which included the double-deficient mice succumbed to myeloproliferative disease resembling human chronic myelogenous leukemia (CML) and chronic myelomonocytic leukemia. The double-deficient mice displayed medullary and extramedullary hyperplasia of granulocyte/macrophage progenitors with leukemic potential, and their myeloid cells showed hyperproliferation and hypo-apoptosis upon treatment and deprivation of cytokines, respectively. Consistently, the mutant myeloid cells showed enhanced Erk and Akt activation upon cytokine stimulation. Moreover, loss of Dok-1 and/or Dok-2 induced blastic transformation of chronic phase CML-like disease in mice carrying the bcr-abl gene, a cause of CML. These findings demonstrate that Dok-1 and Dok-2 are key negative regulators of cytokine responses and are essential for myeloid homeostasis and suppression of leukemia.

Original languageEnglish
Pages (from-to)1681-1687
Number of pages7
JournalJournal of Experimental Medicine
Volume200
Issue number12
DOIs
Publication statusPublished - Dec 20 2004

Fingerprint

Leukemia
Homeostasis
Myeloid Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Cytokines
abl Genes
Leukemia, Myelomonocytic, Chronic
Leukemia, Myeloid, Chronic Phase
Granulocyte-Macrophage Progenitor Cells
Cytokine Receptors
Receptor Protein-Tyrosine Kinases
Protein-Tyrosine Kinases
Hyperplasia
Apoptosis
Proteins

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Yasuda, T., Shirakata, M., Iwama, A., Ishii, A., Ebihara, Y., Osawa, M., ... Yamanashi, Y. (2004). Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. Journal of Experimental Medicine, 200(12), 1681-1687. https://doi.org/10.1084/jem.20041247

Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. / Yasuda, Tomoharu; Shirakata, Masaki; Iwama, Atsushi; Ishii, Asuka; Ebihara, Yasuhiro; Osawa, Mitsujiro; Honda, Kazuho; Shinohara, Hisaaki; Sudo, Katsuko; Tsuji, Kohichiro; Nakauchi, Hiromitsu; Iwakura, Yoichiro; Hirai, Hisamaru; Oda, Hideaki; Yamamoto, Tadashi; Yamanashi, Yuji.

In: Journal of Experimental Medicine, Vol. 200, No. 12, 20.12.2004, p. 1681-1687.

Research output: Contribution to journalArticle

Yasuda, T, Shirakata, M, Iwama, A, Ishii, A, Ebihara, Y, Osawa, M, Honda, K, Shinohara, H, Sudo, K, Tsuji, K, Nakauchi, H, Iwakura, Y, Hirai, H, Oda, H, Yamamoto, T & Yamanashi, Y 2004, 'Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia', Journal of Experimental Medicine, vol. 200, no. 12, pp. 1681-1687. https://doi.org/10.1084/jem.20041247
Yasuda, Tomoharu ; Shirakata, Masaki ; Iwama, Atsushi ; Ishii, Asuka ; Ebihara, Yasuhiro ; Osawa, Mitsujiro ; Honda, Kazuho ; Shinohara, Hisaaki ; Sudo, Katsuko ; Tsuji, Kohichiro ; Nakauchi, Hiromitsu ; Iwakura, Yoichiro ; Hirai, Hisamaru ; Oda, Hideaki ; Yamamoto, Tadashi ; Yamanashi, Yuji. / Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. In: Journal of Experimental Medicine. 2004 ; Vol. 200, No. 12. pp. 1681-1687.
@article{e80933d2c38c4e52b81c0f34e7b01dae,
title = "Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia",
abstract = "Dok-1 and Dok-2 are closely related rasGAP-associated docking proteins expressed preferentially in hematopoietic cells. Although they are phosphorylated upon activation of many protein tyrosine kinases (PTKs), including those coupled with cytokine receptors and oncogenic PTKs like Bcr-Abl, their physiological roles are largely unidentified. Here, we generated mice lacking Dok-1 and/or Dok-2, which included the double-deficient mice succumbed to myeloproliferative disease resembling human chronic myelogenous leukemia (CML) and chronic myelomonocytic leukemia. The double-deficient mice displayed medullary and extramedullary hyperplasia of granulocyte/macrophage progenitors with leukemic potential, and their myeloid cells showed hyperproliferation and hypo-apoptosis upon treatment and deprivation of cytokines, respectively. Consistently, the mutant myeloid cells showed enhanced Erk and Akt activation upon cytokine stimulation. Moreover, loss of Dok-1 and/or Dok-2 induced blastic transformation of chronic phase CML-like disease in mice carrying the bcr-abl gene, a cause of CML. These findings demonstrate that Dok-1 and Dok-2 are key negative regulators of cytokine responses and are essential for myeloid homeostasis and suppression of leukemia.",
author = "Tomoharu Yasuda and Masaki Shirakata and Atsushi Iwama and Asuka Ishii and Yasuhiro Ebihara and Mitsujiro Osawa and Kazuho Honda and Hisaaki Shinohara and Katsuko Sudo and Kohichiro Tsuji and Hiromitsu Nakauchi and Yoichiro Iwakura and Hisamaru Hirai and Hideaki Oda and Tadashi Yamamoto and Yuji Yamanashi",
year = "2004",
month = "12",
day = "20",
doi = "10.1084/jem.20041247",
language = "English",
volume = "200",
pages = "1681--1687",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "12",

}

TY - JOUR

T1 - Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia

AU - Yasuda, Tomoharu

AU - Shirakata, Masaki

AU - Iwama, Atsushi

AU - Ishii, Asuka

AU - Ebihara, Yasuhiro

AU - Osawa, Mitsujiro

AU - Honda, Kazuho

AU - Shinohara, Hisaaki

AU - Sudo, Katsuko

AU - Tsuji, Kohichiro

AU - Nakauchi, Hiromitsu

AU - Iwakura, Yoichiro

AU - Hirai, Hisamaru

AU - Oda, Hideaki

AU - Yamamoto, Tadashi

AU - Yamanashi, Yuji

PY - 2004/12/20

Y1 - 2004/12/20

N2 - Dok-1 and Dok-2 are closely related rasGAP-associated docking proteins expressed preferentially in hematopoietic cells. Although they are phosphorylated upon activation of many protein tyrosine kinases (PTKs), including those coupled with cytokine receptors and oncogenic PTKs like Bcr-Abl, their physiological roles are largely unidentified. Here, we generated mice lacking Dok-1 and/or Dok-2, which included the double-deficient mice succumbed to myeloproliferative disease resembling human chronic myelogenous leukemia (CML) and chronic myelomonocytic leukemia. The double-deficient mice displayed medullary and extramedullary hyperplasia of granulocyte/macrophage progenitors with leukemic potential, and their myeloid cells showed hyperproliferation and hypo-apoptosis upon treatment and deprivation of cytokines, respectively. Consistently, the mutant myeloid cells showed enhanced Erk and Akt activation upon cytokine stimulation. Moreover, loss of Dok-1 and/or Dok-2 induced blastic transformation of chronic phase CML-like disease in mice carrying the bcr-abl gene, a cause of CML. These findings demonstrate that Dok-1 and Dok-2 are key negative regulators of cytokine responses and are essential for myeloid homeostasis and suppression of leukemia.

AB - Dok-1 and Dok-2 are closely related rasGAP-associated docking proteins expressed preferentially in hematopoietic cells. Although they are phosphorylated upon activation of many protein tyrosine kinases (PTKs), including those coupled with cytokine receptors and oncogenic PTKs like Bcr-Abl, their physiological roles are largely unidentified. Here, we generated mice lacking Dok-1 and/or Dok-2, which included the double-deficient mice succumbed to myeloproliferative disease resembling human chronic myelogenous leukemia (CML) and chronic myelomonocytic leukemia. The double-deficient mice displayed medullary and extramedullary hyperplasia of granulocyte/macrophage progenitors with leukemic potential, and their myeloid cells showed hyperproliferation and hypo-apoptosis upon treatment and deprivation of cytokines, respectively. Consistently, the mutant myeloid cells showed enhanced Erk and Akt activation upon cytokine stimulation. Moreover, loss of Dok-1 and/or Dok-2 induced blastic transformation of chronic phase CML-like disease in mice carrying the bcr-abl gene, a cause of CML. These findings demonstrate that Dok-1 and Dok-2 are key negative regulators of cytokine responses and are essential for myeloid homeostasis and suppression of leukemia.

UR - http://www.scopus.com/inward/record.url?scp=19944426550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944426550&partnerID=8YFLogxK

U2 - 10.1084/jem.20041247

DO - 10.1084/jem.20041247

M3 - Article

C2 - 15611294

AN - SCOPUS:19944426550

VL - 200

SP - 1681

EP - 1687

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 12

ER -